View up-to-date information on NGM Biopharmaceuticals Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 06 Dec 2021 | NGM Biopharma Enters into Clinical Trial Agreement with Merck | Partnership | - |
Merck & Co Inc NGM Biopharmaceuticals Inc |
| 05 Jan 2021 | NGM Biopharma Prices Public Offering of Shares for USD125 Million | Equity Offering | - |
NGM Biopharmaceuticals Inc |
| 21 Jan 2020 | NGM Biopharma Enters into Licensing Agreement with Horizon Discovery | Licensing Agreement |
NGM Biopharmaceuticals Inc
|
Horizon Discovery Group Ltd
|
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward